CMS: E-Prescribing Helps Prevent Adverse Reactions

June 24, 2011
Patients who are eligible to enroll in Medicare’s prescription drug program are expected to experience greater safety, increased use of lower-cost

Patients who are eligible to enroll in Medicare’s prescription drug program are expected to experience greater safety, increased use of lower-cost generic equivalents, and more efficient communication between their doctor and pharmacy as a result of a new regulation issued by the Centers for Medicare & Medicaid Services (CMS), it says. The final rule establishes Part D e‑prescribing standards for four types of information: formulary and benefits, medication history, fill status notification, and identification of individual healthcare providers.

  • Formulary and benefits: This standard will allow doctors and other prescribers to communicate with Part D sponsors about which drugs are covered by a Medicare eligible individual's prescription drug benefit plan. Prescribers can also learn which generic prescription drugs might offer lower-cost options for the individual.
  • Medication history: This standard will allow doctors and other providers, as well as dispensers and Part D sponsors, to communicate among themselves about prescribed medications a beneficiary has taken or is taking, including those prescribed by other providers.
  • Fill status notification: This standard will allow providers to receive an e-mail notice from pharmacy or other dispenser telling them that a patient’s prescription has been picked up, not picked up, or has been partially filled.
  • Provider identifier: The final rule requires providers, dispensers, and Part D sponsors to use the National Provider Identifier (NPI) to identify individual healthcare providers in Part D e‑prescribing transactions.

According to CMS, prescribers, dispensers and other providers are not required to implement e‑prescribing, but those who do must comply with the new Medicare standards when using e-prescribing to send prescriptions and prescription related information for covered drugs prescribed for Part D eligible individuals.

This final rule on Part D e‑prescribing standards (CMS-0016-F/CMS-0018-F) and the earlier final rule establishing e‑prescribing foundation standards (CMS-0011-F) are available online.

Sponsored Recommendations

How Digital Co-Pilots for patients help navigate care journeys to lower costs, increase profits, and improve patient outcomes

Discover how digital care journey platforms act as 'co-pilots' for patients, improving outcomes and reducing costs, while boosting profitability and patient satisfaction in this...

5 Strategies to Enhance Population Health with the ACG System

Explore five key ACG System features designed to amplify your population health program. Learn how to apply insights for targeted, effective care, improve overall health outcomes...

A 4-step plan for denial prevention

Denial prevention is a top priority in today’s revenue cycle. It’s also one area where most organizations fall behind. The good news? The technology and tactics to prevent denials...

Healthcare Industry Predictions 2024 and Beyond

The next five years are all about mastering generative AI — is the healthcare industry ready?